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A B S T R A C T
Objective: To establish the reliability and validity of a self-report measure designed to assess self-efficacy
for hypertension treatment adherence.
Methods: This investigation was embedded within a six-month randomized clinical trial (RCT), which
demonstrated that a tailored, stage-matched intervention was more effective at improving hypertension
control than usual care among individuals (n = 533) with repeated uncontrolled hypertension. The
instrument used to assess self-efficacy for hypertension treatment adherence (SE-HTA) comprised three
subscales that assessed diet self-efficacy (DSE), exercise self-efficacy (ESE), and medication self-efficacy
(MSE). To determine SE-HTA validity and reliability, we assessed internal consistency using Cronbach’s α
coefficients, conducted exploratory factor analysis, and evaluated convergent and discriminant validity,
as well as test-retest reliability using Spearman’s r correlation coefficients.
Results: Cronbach’s α (internal consistency) values for DSE, ESE, and MSE were 0.81, 0.82 and 0.74. Factor
analysis and the scree plot demonstrated three distinct factors, which correspond to the three subscales
contained in the SE-HTA instrument. SE-HTA possessed good convergent and discriminant validity, and
moderate test-retest reliability.
Conclusion: The SE-HTA instrument containing diet, exercise, and medication adherence subscales is valid
and reliable in adults with uncontrolled hypertension.
Practice implications: This SE-HTA instrument measures self-efficacy and could help facilitate behavior
change in hypertension.
Published by Elsevier B.V.
1. Introduction
Of the approximately 75 million American adults (29%) with
hypertension, approximately half (48.3%) have controlled blood
pressure (BP) [1]. Left untreated, uncontrolled BP leads to heart
failure, stroke, myocardial infarction and other serious cardiovas-
cular complications, the most common cause of mortality in the
United States [2]. Fortunately, treatment can lower BP, decrease
cardiovascular disease risk, and reduce mortality [3]. Diet, exercise,
and medication adherence are crucial to control hypertension and
prevent cardiovascular complications [4]. Despite advances in
treating hypertension, failure to adhere to recommended treat-
ment is a significant barrier to hypertension control [5].
The concern with suboptimal treatment adherence, the high
prevalence of uncontrolled hypertension, and the critical need to
achieve more effective hypertension control was the basis for a
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f behaviors within the context of individual decision-making, and
dentifies intermediate or dependent constructs that facilitate
ransitions through successive behavioral stages. Self-efficacy, a
ey TTM construct, influences this progression through the stages
f change. However, even though self-efficacy has been studied
xtensively, a reliable, valid, and easy-to-administer instrument
ocusing on diet, exercise, and medication adherence to assess self-
fficacy for following hypertension treatment for use with diverse
articipants is not available. A self-efficacy for hypertension
reatment adherence instrument designed to address this need
Table 1), hereafter referred to as “SE-HTA,” was evaluated. SE-HTA
as designed for this hypertension study and comprised three
ubscales relevant to hypertension treatment: diet self-efficacy
DSE), exercise self-efficacy (ESE), and medication self-efficacy
MSE).
Self-efficacy is a well-established construct of Social Cognitive
heory, and refers to an individual’s confidence that he or she can
uccessfully engage in a specific behavior or achieve a desired goal
7]. Participant self-efficacy is a strong predictor of engagement in
elf-management strategies for managing chronic diseases [8–14].
elf-efficacy theory posits that an individual’s belief in his or her
own ability to engage in behavior change is a strong determinant of
actual behavior change. Thus, quantifying participant self-efficacy
is valuable for designing and assessing the effectiveness of tailored
self-management programs and may be a useful predictor of other
health outcomes.
While there are validated self-efficacy instruments, most are
not relevant to cardiovascular disease [15–20]. Two widely used
validated instruments, the MASES (Medication Adherence Self-
Efficacy Scale) and the HBP SCP (High Blood Pressure Self-Care
Profile), do measure self-efficacy in hypertension; however, these
instruments are limited to medication self-efficacy and were
validated in primarily African-American participants [10,12]. A
recent meta-analysis describes nine independently validated
hypertension self-efficacy instruments [21]. Unfortunately, none
encompass the modifiable behaviors of diet, exercise, and
medication adherence that are crucial to managing hypertension.
Considering the enormous burden of hypertension, there is a
pressing need for a comprehensive self-efficacy scale for hyper-
tension treatment that specifically assesses behaviors relevant to
self-management of hypertension in diverse adult populations.
Thus, the objective of this study was to assess the validity and




This evaluation was conducted within a RCT testing the
effectiveness of a telephone-delivered, transtheoretical stage-
matched intervention in veterans with uncontrolled hypertension
[6,22]. We randomly assigned participants to one of three groups:
1) a telephone-delivered, tailored behavioral intervention, 2) a
telephone-delivered, non-tailored health education intervention,
and 3) the usual care standard. After a six-month intervention
period, participants were followed for a six-month observation
period of no intervention to assess intervention sustainability. In
all three groups, we assessed systolic BP at baseline, six months,
and 12 months. Other measurements included assessing adher-
ence to the Dietary Approaches to Stop Hypertension (DASH) diet
using food frequency questionnaires, aerobic exercise adherence in
hours per week from the seven-day Physical Activity Recall
measure, and medication adherence with the four-item Morisky
Medication Adherence Questionnaire [23–25]. Stages of change for
diet, exercise, and medication adherence were independently
assessed using validated questions [26]. Details about each of the
three SE-HTA subscale measures are contained in Table 1 and in the
“Self-Efficacy Measure for Diet, Exercise, and Medication Adher-
ence” section below.
2.2. Participants
We randomized participants to one of the three arms for six
months of intervention followed by six months of observation. All
participants had a follow-up assessment three months after
randomization to assess transtheoretical constructs and other
outcomes such as adherence to medication, diet, and exercise. Our
analysis of the SE-HTA instrument utilized baseline data from the
RCT and the three-month data. The study was conducted from
January 2006 to September 2011 at the Veterans Affairs Medical
able 1
he Self-Efficacy for Hypertension Treatment Adherence (SE-HTA)a Instrument.
Diet Self-Efficacy (DSE) Subscale
Please indicate how confident you are that you would regularly continue to
follow the diet for better control of high blood pressureb if each of the
following situations were to happen to you.
1. When I am eating with family or friends and no one but me is on a diet.
2. When I am traveling or on vacation.
3. When I am in a rush/hurry.
4. When I am under a lot of stress.
5. When I don't have easy access to healthy foods.
6. When the risk of going off my diet seems low to me.
Exercise Self-Efficacy (ESE) Subscale
Please indicate how confident you are that you will continue to exercisec if each
of the following situations were to happen to you.
1. When I am under a lot of stress.
2. When I feel I don’t have the time.
3. When I have to exercise alone.
4. When I don’t have access to exercise equipment.
5. When I am spending time with friends or family who do not exercise.
6. When it’s raining or snowing.
Medication Self-Efficacy (MSE) Subscale
Please indicate how confident you are that you will continue to take your
medications as prescribedd if each of the following situations were to happen
to you.
1. When I am under a lot of stress.
2. When I feel I don’t have the time.
3. When I don’t have easy access to the medications (i.e. living far from a
pharmacy or not having pills with you when you need them.
4. When the risk of not taking medication seems low to me.
5. When my family or friends don’t encourage me to take my medication.
a Participants respond on a five-point Likert scale, ranging from “1 = Not
onfident at All” to “5 = Completely Confident”.
b The dietary goal was the DASH diet pattern, which we operationalized as
llowing the DASH diet for six or seven days per week (>80% adherence). To follow
he DASH diet typically means decreasing sodium intake and increasing the intake
f nutrient rich foods, such as those that contain potassium, and increasing the
mount of fiber and protein in the diet. It is also important to cut back on foods that
ontain saturated fat and cholesterol. This diet is rich in fruits, vegetables, whole
rains, and low-fat dairy foods, and must be followed according to your doctor’s
dvice, for all meals every day.
c “Appropriate exercise” was defined as 20 min of moderate intensity exercise for
t least three days a week.
d Medication adherence was defined as  80% adherence (Haynes et al., 2005)
hich we operationalized as taking the medication as prescribed > five days per
eek.
2
Center clinics in Brooklyn and Manhattan. We identified patients
with uncontrolled hypertension from review of electronic medical
records. Research assistants approached patients during their
subsequent routine clinic visit and informed them about the study.
Written informed consent was obtained from interested patients
who were then deemed eligible if they had uncontrolled
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tension was defined as systolic BP  130 mm Hg or diastolic
BP  80 mm Hg in patients with diabetes mellitus or chronic
kidney disease, and as systolic BP  140 mm Hg or diastolic
BP  90 mm Hg in all other patients (as defined by the hyperten-
sion guidelines at the time of the study) [27]. The flow of
participants is shown on Fig. 1. Details are in previous study
publications [6,28–30].
Potential subjects were excluded if they had a cardiovascular
disease event less than six months prior; had class III or IV heart
failure; had severe psychiatric illness, AIDS, tuberculosis, lupus,
end-stage renal failure, or limited life expectancy of less than one
year. Other exclusions included lack of telephone access, inability
to follow the study protocol, recent major surgery less than three
months prior to enrollment, unavailability for follow-up (such as
those living temporarily in the area), or inability to provide
informed consent. IRB approval was obtained prior to study
initiation and all subjects provided written informed consent.
2.3. Development of self-efficacy measure
2.3.1. Theoretical framework and constructs
Our intervention is based on the Transtheoretical Model of
behavioral change [22]. We reviewed the self-efficacy instruments
available for research from the University of Rhode Island Cancer
Prevention Research Center [31]. Since there was no readily
available instrument for diet or medication adherence, we planned
to develop a self-efficacy scale for measuring adherence to
hypertension treatment. We first conducted a literature search
and identified comparable measures for diet and medication
adherence [32,33]. Since the goal of the RCT was to test the effect of
the Transtheoretical Model-based intervention on BP control, and
as the existing, comparable self-efficacy measures were overly
lengthy, we needed to develop a shorter instrument to reduce
respondent burden while preserving fidelity to the theoretical
constructs. The criterion diet, exercise, and medication adherence
behaviors that are needed to achieve optimal hypertension
management are well known. Thus, we built on the valid and
reliable self-efficacy scales that were readily available through the
Transtheoretical Model measures website, particularly the exercise
subscale. Using deductive methods, we used a similar structure to
the exercise subscale for our diet and medication subscales by
building on the domains and the associated items from the
cholesterol-lowering diet scale and the hypertension medication
scale [32,33].
2.3.2. Expert review and pilot testing the instrument
The first draft of the scale was developed and adapted by the PI,
and was individually and collectively evaluated by a study team
panel. This included the PI, two senior faculty behavioral science
co-investigators, several physicians (a cardiologist, a geriatrician,
and a primary care physician), three PhD clinical psychologists,
three research coordinators and three research assistants. This
panel reviewed the measures individually to ensure that each
question was relevant to self-efficacy for adhering to hypertension
treatment. The panel paid particular attention to the format of the
items, the wording of the items, the types of responses that the
question was designed to induce and whether it was relevant to
hypertension management in a veteran population. The panel
reached a consensus on the wording of each question within the
framework of previously validated instruments. The refined
instrument was then initially pilot tested among our research
group for clarity, duration and face validity. Each team member
provided input on the relevance of each item, and the decision to
keep or eliminate items was based on the judgement of the
physicians, clinical psychologists and senior behavioral scientists.
The instrument was subsequently administered to the first study
participants, and its performance was reviewed to confirm its
relevance to their experience of managing hypertension, clarity,
and production of appropriate responses.
2.3.3. Final instrument
The resulting SE-HTA instrument (Table 1) comprised three
subscales that focused on relevant aspects of self-efficacy for
successful hypertension management: DSE (six items), ESE (six
items), and MSE (five items). Before administering the SE-HTA,
research assistants defined to the participant what constituted the
BP-lowering diet, exercise recommendations in hypertension and
appropriate medication adherence. The dietary goal was the DASH
diet [34,35], which we operationalized as following the DASH diet
for > five days per week (>80% adherence). Prior to the 2008
Physical Activity Recommendations for Americans [36], the
exercise goal was 20–60 min of moderate to high-intensity
exercise performed  three times a week [37]. Since the majority
of study participants were over the age of 60 with other
comorbidities in addition to hypertension; in the interest of
safety, we conservatively defined “appropriate exercise” as 20 min
of moderate intensity exercise for at least three days a week.
Finally, we defined medication adherence as  80% adherence [38],
which we operationalized as taking the medication as pre-
scribed > five days per week. In these three subscales, each item
presents a different situation that could present a challenge for
adhering to one of these three health behaviors. Participants wereFig. 1. Flow diagram demonstrating enrollment and participation through baseline
study visit, randomization, and 3-month follow up (among Usual Care group).
3
asked to rate their confidence in maintaining their diet, exercise, or
medication adherence in each situation, on a five-point Likert
scale, ranging from “1 = Not Confident at All” to “5 = Completely
Confident”. The total score for each subscale is therefore an
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After calculating descriptive statistics, analyses were indepen-
ently performed for the three subscales (diet, exercise, and
edication adherence) of the SE-HTA instrument. Internal consis-
ency was determined by calculating the Cronbach’s α coefficient,
herein a value > 0.70 is considered to be internally consistent
39,40]. Test-retest reliability was assessed using the Spearman’s r
orrelation coefficient using baseline and three-month data.
onvergent validity for the DSE, ESE, and MSE subscales was
ssessed by calculating the Spearman’s r correlation coefficient for
ach of the three subscales with the corresponding criterion
easure. DSE was compared to the DASH score from Willett food
requency questionnaires, which consists of scores ranging from
ight to 40 with higher scores corresponding to improved dietary
dherence [25]. ESE was compared to aerobic exercise measured in
ours per week from the Sallis seven-day physical activity recall,
hich specifically assesses hours per week of moderate aerobic
xercise [24]. MSE was compared to medication adherence deter-
ined from the four-item Morisky Scale, which consists of scores
anging from zero to four with higher scores representing greater
edication adherence [26]. Discriminant validity was examined
singpsychosocialsupportfordiet(encouragement)orpsychosocial
upport forexercise participation measures[41].Thesemeasuresare
-item and12-item instruments that assessvarying levelsof support
or diet encouragement and exercise participation respectively. We
hose Spearman’s r coefficient rather than Pearson’s r coefficient
ecause it is more conservative and requires fewer assumptions.
actor Analysis was performed on all 17 items of the SE-HTA
nstrument using baseline data and examined using a Cattell Scree
lot. All analyses were conducted with SAS 9.4 (SAS Institute Inc.,
ary, North Carolina).
. Results
Our analysis utilized baseline data measurements (n = 533) as
ell as data from the three-month follow-up in the usual care
roup (Fig. 1). Study participants were primarily unemployed and
nmarried older men; approximately equal numbers were white
r black (Table 2).
The DSE and ESE subscales included six items each (maximum
core 30), while the MSE subscale included five items (maximum
core 25). The mean (standard deviation) for the DSE subscale was
8.41 (4.94), for ESE 20.09 (5.27), and for MSE 19.85 (3.49). The
edian (lower quartile, upper quartile) for the DSE subscale was
8 (15,21), ESE 20 (16,24), and MSE 20 (18,22). In general, MSE
cores were relatively high with the greatest consistency, while
SE and ESE scores were lower with greater variability relative to
SE.
.1. Internal consistency
Internal consistency was determined by calculating Cronbach’s
 coefficients using baseline data. The three subscales (DSE, ESE,
nd MSE) each measure self-efficacy of a different factor
nfluencing hypertension control and were examined indepen-
ently. Internal consistency for the three subscales varied slightly.
he six-item DSE scale demonstrated good internal consistency
Cronbach α = 0.81). Similarly, the six-item ESE scale also
emonstrated good internal consistency (Cronbach α = 0.82). The
variation in measurements over time, which may affect test-
retest reliability. Furthermore, test-retest reliability is highly
dependent on the length of time between assessments. In this
RCT, participants returned for a short three-month visit to
capture medication adherence and to assess behavioral
constructs. While this is longer than ideal for test-retest,
which is typically about two weeks [43], we took this practical
opportunity to examine test-retest reliability at three months.
Test-retest reliability was assessed using a Spearman’s r
correlation coefficient in participants from the usual care arm
(n = 177 at baseline, n = 151 at three months, 14.7% attrition)
since the other two arms received interventions that may have
increased self-efficacy. Test-retest reliability was 0.58
(p < 0.0001) for DSE, 0.57 (p < 0.0001) for ESE and 0.49
(p < 0.0001) for MSE assessed from the 151 participants with
both baseline and three-month assessments.
3.3. Convergent validity
Construct validity quantifies the extent to which inferences
can be made from the study. To determine construct validity,
convergent validity was first examined. A Spearman’s r
coefficient was calculated for each of the three SE-HTA scales
to examine convergent validity. Baseline measurements for
each respective self-efficacy scale were correlated to the
relevant criterion measure (Table 3). DSE was compared to the
DASH score, from Willett food frequency questionnaires, for a
Spearman coefficient of 0.17 (p = 0.0004). ESE was compared to
aerobic exercise in hours per week, from the Sallis seven-day
physical activity recall, for a Spearman coefficient of 0.27 (p <
0.0001). MSE was compared to medication adherence, from the
four-item Morisky Scale, for a Spearman coefficient of 0.24 (p <
0.0001).
3.4. Discriminant validity
Discriminant Validity contributes to construct validity by
demonstrating lack of correlation between self-efficacy and
unrelated measures. Baseline measurements for each of the three
self-efficacy subscales were compared to psychosocial support for
diet (encouragement) or psychosocial support for exercise
participation measures, and Spearman’s r coefficient for each of
the three subscales was calculated (Table 3). Psychosocial support
for diet encouragement was compared to DSE, ESE, and MSE for
Spearman coefficients of 0.065 (p = 0.13), 0.051 (p = 0.23), and
0.047 (p = 0.28) respectively. Psychosocial support for exercise
participation was compared to DSE, ESE, and MSE for Spearman
coefficients of 0.059 (p = 0.18), 0.07 (p = 0.11), and 0.001 (p = 0.97)
respectively.
3.5. Exploratory factor analysis
Common factor analysis was performed by using the oblique
rotation and the squared multiple correlation as estimating
communalities from the baseline data. We used all 17 items from
the instrument for the factor analysis. We extracted three factors
based on the scree plot (Fig. 2), which demonstrated a natural bend
at four factors within the structure. Furthermore, total variance
that was explained along with eigenvalues verified the structure to
contain three factors. Total variance explained by factors I, II, and IIIve-item MSE scale demonstrated slightly lower but acceptable
nternal consistency (Cronbach α = 0.74).
.2. Test-retest reliability
Self-efficacy is a psychological construct that varies over
ime and not permanently static [42]. This can result in4
were 76.3%, 18.9%, and 12.6%, respectively. Eigenvalues were 4.9,
1.2, and 0.8, respectively. The presence of these three distinct
factors suggests that the SE-HTA instrument examines three
different constructs, i.e. the three different subscales. The factor
loadings (Table 4) corresponded to the conceptualized three-
construct design of the SE-HTA instrument. The first factor
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factor consisted of all six questions for the DSE subscale, and the
third factor contained all five questions from the MSE subscale.
Although the eigenvalue for the third factor was less than one, the
item was retained since it was composed of all the medication-
taking items on the SE scale.
4. Discussion
We evaluated the validity and reliability of a self-efficacy for
hypertension treatment adherence instrument, the SE-HTA. We
found the SE-HTA instrument to be a sufficiently valid and reliable
tool for assessing self-efficacy for diet, exercise, and medication
adherence in adults with uncontrolled hypertension. The Cron-
bach’s α coefficients for each instrument subscale support high
internal consistency and the test-retest correlations suggest
moderate reliability. When the values for DSE, ESE, and MSE were
subscales. The three factors were determined from the scree plot,
which demonstrated a distinct natural bend at factor four. Factor
loadings attribute three distinct factors to the structure of our self-
efficacy instrument that correspond to the three subscales.
Successful self-management of chronic disease is behaviorally
dependent. Individuals who possess high self-efficacy are more
likely to make necessary changes in lifestyle and maintain newly
adopted healthy behaviors. Thus, having a valid and reliable
methods to assess and ultimately improve self-efficacy is desirable
for optimizing behaviors for sustained hypertension control. The
SE-HTA instrument was designed to examine self-efficacy in
participants with uncontrolled hypertension and is unique in
measuring this construct in a diverse population of adults with
hypertension. It is both appropriately narrow in scope and
comprehensive in its simultaneous examination of diet, exercise,
and medication adherence self-efficacy. Its comprehensive nature
did not compromise practicality, as study participants responded
Table 2
Characteristics of Participants from the Hypertension Control Trial (n = 533).
Characteristic Percent Mean (SD) Median Lower Quartile Upper Quartile





Hispanic origin (any race) 15.2
Other 5.3
Married 36.9





IHD (heart attack) 12.8
Revascularization 16.2
Hyperlipidemia 24.1
EGFR 81.3 (1.58) 79.0 61.0 94.0
Hypertension control 42.6
Systolic BP, mmHg 136.7 (0.67) 135.7 126.3 146.7
Diastolic BP, mmHg 75.52 (0.50) 75.7 67.3 83.83
Aerobic exercise in hours/week 4.9 (0.29) 2.8 1.0 6.25
DASH score 23.8 (0.25) 24.0 20.0 27.0
Medication Adherence by Morisky scale 3.3 (0.04) 4.0 3.0 4.0
Number of antihypertensive medications 2.7 (0.06) 3.0 2.0 4.0




RCT Randomized Clinical Trial; BP Blood Pressure; DASH Dietary Approaches to Stop Hypertension; EGFR, Estimated Glomerular Filtration Rate; IHD, Ischemic Heart Disease.
a Stages of change were determined using validated questions (Nigg et al., 1999). These include precontemplation (no plans to adhere in <6 months), contemplation (plans
to adhere in 1–6 months), preparation (plans to adhere within 1 month), action (adherence for <6 months), and maintenance (adherence for 6 months).
Table 3

















Diet Self Efficacy 0.17** – – 0.065 ns 0.059 ns
Exercise Self Efficacy – 0.27** – 0.051 ns 0.07 ns
Medication Self Efficacy – – 0.24** 0.047 ns 0.001 ns
** p < 0.001.
ns No significant difference (p > or = 0.05).compared to DASH scores, aerobic exercise in hours per week, and
medication adherence, the correlations supported convergent
validity. The lack of correlation between self-efficacy scores and
psychosocial support for diet or exercise confirmed discriminant
validity. Moreover, exploratory factor analysis demonstrated that
three distinct factors could be attributed to the DSE, ESE, and MSE5
well to the instrument. The instrument was designed to be used in
a large RCT and was evaluated as part of the study.
Medication adherence measured by the Morisky Scale was
relatively high. We attribute this to the fact that our participants
were predominantly elderly men obtaining care at Veterans Affairs
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harmacy at little or no cost, b) medication renewals are
onvenient and c) patients obtain their care in patient-centered
edical homes where they have good access to their providers and
re well educated regarding their medications. Furthermore, the
istribution of scores across the three subscales was generally
igh. There are three reasons for this: First, the instrument
omprised self-reported assessments demonstrating a partici-
ant’s self-efficacy in maintaining health behaviors, in a study
opulation consisting of older veterans who are generally adherent
o instructions. Second, this study was performed as part of a RCT
xamining telephone-delivered behavioral interventions. Third,
he RCT included a run-in period, where participants with lower
individual’s personal perception determines self-efficacy and may
change over time [44], future assessments of SE-HTA test-retest
reliability would benefit from measurements taken closer in time.
The other measure of reliability, internal consistency, was high,
using the typical Cronbach’s α cut-off of >0.70 as well as the more
contemporary threshold of >0.80 for reliability [45,46]. Second,
considering that this was not a standalone project but part of a
large RCT, we needed the measures ready for deployment before
the RCT began, i.e., in only a few months. Consequently, more
detailed patient interviews and formal analyses were beyond the
scope of the project. Since prior work by others had demonstrated
the essential validity and reliability of the constructs with which
we were working, we did not conduct more rigorous interviews or
focus groups, or formal analyses-based item reduction. Finally, it
should be noted that data collection for this study was completed
in 2011. Nevertheless, the primary modalities for hypertension
treatment remain diet, exercise, and medications, which are the
primary assessments from this instrument. While the instrument
defines a criterion for diet and exercise, for medication adherence,
it focuses on adherence and does not specify particular medi-
cations or class of medications. Therefore, despite data being from
2011, we believe that the instrument will have wide applicability.
Strengths of this study include an instrument that is both short
and comprehensive (17 items spanning three clinically relevant
subscales of diet, exercise, and medication adherence), large
sample size (n = 533), and diversity (39.8% white, 39.8% black, and
15.2% non-white Hispanic). The sample is representative of urban
Veterans with hypertension given that participants were primarily
older men with comorbidities and were predominantly white
(non-Hispanic) and black participants. Considering the substantial
burden of hypertension, the increasingly common structure of
“medical homes” across the country, the diverse study sample, and
the high prevalence of comorbidities, these findings should be
applicable to a broad range of patients with hypertension.
Hypertension and cardiovascular disease are concerns for non-
Fig. 2. Exploratory Factor Analysis of the 17 Self-Efficacy Questions from the SE-HTA Instrument.
able 4
otated Factor Pattern of SE-HTA Instrument with Standardized Regression
oefficients.
Item Number Factor 1 Factor 2 Factor 3
Diet Self-Efficacy 1 0.04691 0.71891 0.04146
Diet Self-Efficacy 2 0.00449 0.73798 0.01129
Diet Self-Efficacy 3 0.10666 0.71396 0.00864
Diet Self-Efficacy 4 0.03054 0.68871 0.09259
Diet Self-Efficacy 5 0.03054 0.68715 0.07868
Diet Self-Efficacy 6 0.01352 0.66252 0.01099
Exercise Self-Efficacy 1 0.75087 0.08062 0.08212
Exercise Self-Efficacy 2 0.73915 0.00932 0.02591
Exercise Self-Efficacy 3 0.76926 0.06416 0.02814
Exercise Self-Efficacy 4 0.65449 0.04346 0.07596
Exercise Self-Efficacy 5 0.68117 0.05617 0.12927
Exercise Self-Efficacy 6 0.68015 0.01903 0.04919
Medication Self-Efficacy 1 0.07754 0.00039 0.62807
Medication Self-Efficacy 2 0.09022 0.03259 0.78029
Medication Self-Efficacy 3 0.02749 0.12043 0.53953
Medication Self-Efficacy 4 0.14263 0.06716 0.75198
Medication Self-Efficacy 5 0.05119 0.10870 0.71836evels of adherence may have dropped out before randomization.
This study has certain limitations. First, the test-retest
eliability assessments occurred three months apart, which is a
onger than usual for test-retest. The purpose of test-retest
eliability is to measure whether an instrument can reliably
eplicate the result in the same situation and population. Since an6
Veterans and among patients outside of health-maintenance
organizations. The treatment of hypertension in men and women,
and in patients from different community settings are not
significantly different. Therefore, while the processes and out-
comes from this study are directly relevant to veterans, the findings
should be generalizable to patients from other settings.
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instrument employed in this study demonstrates similar proper-
ties in other studies among different patient populations and
settings.
Finally, tailored interventions in hypertension show signifi-
cant potential to improve self-management and enhance
hypertension control. Motivating patients to initiate and
maintain behavioral change is crucial to patient-centered
treatment. Thus, effectively measuring self-efficacy in a clinical
setting may not only benefit the quality of treatment, but may
also increase overall efficiency.
4.1. Conclusion
Existing instruments for assessing self-efficacy among adults
with hypertension with demonstrated validity and reliability are of
limited scope and utility. The SE-HTA instrument that was
developed and used in a successful hypertension RCT is valid
and reliable for measuring self-efficacy for diet, exercise, and
medication adherence in adults with hypertension. Additional
efforts to further evaluate validity and reliability of this short self-
efficacy instrument in other population subgroups would comple-
ment these findings. Moreover, future research with this instru-
ment, or an adapted version, could provide potentially useful
information regarding the effectiveness of the instrument for
understanding and measuring self-efficacy in other disease states
such as diabetes, dyslipidemia, or heart failure; all of which involve
the challenges of changing behavior across multiple domains.
4.2. Practice implications
Self-efficacy, which is central to many behavioral theories and
models, is a critical construct underlying adherence to health
behaviors and is a principal focus of behavioral intervention for
chronic disease self-management. A valid and reliable instrument
for use among adults with hypertension can assess self-efficacy
and may help facilitate behavior change for improved health. Thus,
having a valid and reliable instrument for assessing and ultimately
improving self-efficacy is important for optimizing behaviors for
sustained hypertension control.
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